Jack H. Dean
Director · Acurx Pharmaceuticals, Inc.
Individual
- 2026
- Apr 22, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jack H. Dean's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Stephen Hoge - $45.45M in MRNA purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jack H. Dean?
Jack H. Dean is a corporate insider, tracked as Director of Acurx Pharmaceuticals, Inc. (ACXP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jack H. Dean last file a Form 4?
The only primary Form 4 on record is dated 22 April 2026.